| Association between higher levels of sexual function, activity, and satisfaction and self‐rated successful aging in older postmenopausal women WK Thompson, L Charo, IV Vahia, C Depp, M Allison, DV Jeste Journal of the American Geriatrics Society 59 (8), 1503-1508, 2011 | 142 | 2011 |
| Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes AB Gardner, LM Charo, AK Mann, DS Kapp, RN Eskander, JK Chan Clinical & experimental metastasis 37, 107-113, 2020 | 91 | 2020 |
| Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019 LM Charo, SC Plaxe F1000Research 8, 2019 | 64 | 2019 |
| Rapid dissemination of practice-changing information: a longitudinal analysis of real-world rates of minimally invasive radical hysterectomy before and after presentation of … LM Charo, F Vaida, RN Eskander, P Binder, C Saenz, M McHale, S Plaxe Gynecologic Oncology 157 (2), 494-499, 2020 | 36 | 2020 |
| Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients LM Charo, RN Eskander, R Okamura, SP Patel, M Nikanjam, RB Lanman, ... Molecular oncology 15 (1), 67-79, 2021 | 34 | 2021 |
| Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States LM Charo, J Jou, P Binder, SF Hohmann, C Saenz, M McHale, ... Gynecologic oncology 159 (3), 681-686, 2020 | 30 | 2020 |
| A novel PRKAR1B-BRAF fusion in gastrointestinal stromal tumor guides adjuvant treatment decision-making during pregnancy LM Charo, AM Burgoyne, PT Fanta, H Patel, J Chmielecki, JK Sicklick, ... Journal of the National Comprehensive Cancer Network 16 (3), 238-242, 2018 | 19 | 2018 |
| Real-world data from a molecular tumor board: improved outcomes in breast and gynecologic cancers patients with precision medicine LM Charo, RN Eskander, J Sicklick, KH Kim, HJ Lim, R Okamura, S Lee, ... JCO Precision Oncology 6, e2000508, 2022 | 11 | 2022 |
| Introduction: obesity and lifestyle issues in women L Charo, DY Lacoursiere Clinical obstetrics and gynecology 57 (3), 433-445, 2014 | 10 | 2014 |
| HIPEC after neoadjuvant chemotherapy and interval debulking is associated with development of platinum-refractory or-resistant disease J Jou, Z Zimmer, L Charo, C Yau, C Saenz, R Eskander, M McHale, ... Gynecologic oncology 161 (1), 25-33, 2021 | 8 | 2021 |
| Trends and geographic variation in women's representation as principal investigators (PI) in phase 3 gynecologic oncology clinical trials J Jou, A Brodsky, L Charo, P Binder, C Saenz, RN Eskander, M McHale, ... Gynecologic oncology 162 (2), 389-393, 2021 | 5 | 2021 |
| Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors MV Homer, LM Charo, L Natarajan, C Haunschild, K Chung, JJ Mao, ... Menopause 24 (6), 663-668, 2017 | 5 | 2017 |
| Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors LM Charo, MV Homer, L Natarajan, C Haunschild, K Chung, JJ Mao, ... Journal of Obstetrics and Gynaecology 41 (3), 447-452, 2021 | 4 | 2021 |
| Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer J Jou, L Charo, M Hom-Tedla, K Coakley, P Binder, C Saenz, ... Gynecologic oncology 163 (2), 299-304, 2021 | 3 | 2021 |
| Lymph node evaluation in endometrial cancer patients after the FIRES trial (534) M Hom-Tedla, K Coakley, L Charo, J Jou, I Bondre, M McHale, ... Gynecologic Oncology 166, S261-S262, 2022 | | 2022 |
| Real-world data from a Molecular Tumor Board: improved outcomes in gynecologic and breast cancer patients with precision medicine L Charo, R Eskander, J Sicklick, KH Kim, HJ Kim, R Okamura, R Schwab, ... Gynecologic Oncology 162, S257-S258, 2021 | | 2021 |
| Trends and regional variation in women's representation as principal investigators (PI) in phase III gynecologic oncology clinical trials J Jou, A Brodsky, L Charo, P Binder, C Saenz, R Eskander, M McHale, ... Gynecologic Oncology 162, S314-S315, 2021 | | 2021 |
| Patients with stage 3B endometrial cancer receive less chemotherapy, more radiation and have worse survival than other stage 3 EC patients J Jou, L Charo, M Hom, K Coakley, P Binder, C Saenz, R Eskander, ... Gynecologic Oncology 162, S231, 2021 | | 2021 |
| Heated intraperitoneal chemotherapy (HIPEC) use for ovarian cancer in the United States increases after publication of clinical trial and is associated with higher short-term … LM Charo, J Jou, PS Binder, CC Saenz, MT McHale, RN Eskander, ... Gynecologic Oncology 159, 53-54, 2020 | | 2020 |
| Mortality after ovarian cancer (OC) surgery is increased at low volume hospitals (LVH) compared to high volume hospitals (HVH): Black women incur the greatest excess risk LM Charo, AM Barrie, PS Binder, CC Saenz, MT McHale, RN Eskander, ... Gynecologic Oncology 159, 302, 2020 | | 2020 |
